EGFR and non-small cell lung carcinoma: Our findings agree with the results of previous studies that have demonstrated that resected EGFR-positive NSCLC was associated with similar, if not higher, recurrence risk compared with wildtype EGFR NSCLC, regardless of EGFR subtype,4,13,15 although this did not translate into poorer OS.